Divyashree M, Mani MK, Reddy D, Kumavath R, Ghosh P, Azevedo V
Congress has been concerned about this for a while
Personalized Tirzepatide+ is a compounded formulation containing the same active pharmaceutical ingredient (tirzepatide) found in the FDA-approved medications Zepbound and Mounjaro
At 2.5mg/ml, that same one-unit error equals only 0.025mg
The trajectory is clear: the FDA is systematically closing every legal pathway for compounded GLP-1 production
The results of early clinical trials with ARO-ANG3 demonstrated reductions in circulating levels of ANGPTL3 of up to 84%, reductions in circulating triglyceride levels of up to 58%, and reductions of non-HDL cholesterol of up to 26%